Drug intelligence / Profile preview

DTP-HepB-IPV-Hib vaccine (LG Chem)

Development stage: Approved
Lead developer: LG Chem
Modality: Vaccines & Immunotherapeutics
Administration: Intramuscular

Overview

The DTP-HepB-IPV-Hib vaccine is a hexavalent (6-in-1) combination pediatric immunization that protects against six serious diseases: diphtheria, tetanus, pertussis (whooping cough), hepatitis B, poliomyelitis, and Haemophilus influenzae type b infections. It contains inactivated or toxoid components for each disease and works by stimulating the immune system to produce protective antibodies. The primary indication is the prevention of these diseases in infants and young children. This combination reduces the number of injections required compared to separate vaccines[1][3][7]. Developers include LG Chem and Sanofi[6][8].

Brand names: VaxelisSHAN6SHAN-6SHAN 6
Other names: 6-in-1 vaccineDTaP/IPV/Hib/HepB vaccinediphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-haemophilus influenzae type b vaccine

Beyond the preview

Go deeper on DTP-HepB-IPV-Hib vaccine (LG Chem).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DTP-HepB-IPV-Hib vaccine (LG Chem).

Explore the full profile